{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:19:02Z","timestamp":1792696742073,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"am","delay-in-days":298,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32DK007639-30"],"award-info":[{"award-number":["5T32DK007639-30"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jss.2023.12.056","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T23:57:55Z","timestamp":1711497475000},"page":"14-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel Oridonin Analog CYD0682 Inhibits Hepatic Stellate Cell Activation via the Heat Shock Protein 90\u2013Dependent STAT3 Pathway"],"prefix":"10.1016","volume":"298","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8958-4521","authenticated-orcid":false,"given":"Jana E.","family":"Dejesus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi S.","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2023.12.056_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1997","article-title":"Trends in the burden of chronic liver disease among hospitalized US adults","volume":"3","author":"Hirode","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jss.2023.12.056_bib3","first-page":"113","article-title":"Current management of alcoholic hepatitis and future therapies","volume":"4","author":"Saberi","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.jss.2023.12.056_bib5","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jss.2023.12.056_bib6","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","article-title":"Transforming growth factor-\u03b2 (TGF-\u03b2) directly activates the JAK1-STAT3 Axis to induce hepatic fibrosis in coordination with the SMAD pathway","volume":"292","author":"Tang","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jss.2023.12.056_bib7","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.3390\/ijms19061787","article-title":"STAT3 interactors as potential therapeutic targets for cancer treatment","volume":"19","author":"Laudisi","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jss.2023.12.056_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejmech.2016.06.015","article-title":"Discovery and development of natural product oridonin-inspired anticancer agents","volume":"122","author":"Ding","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jss.2023.12.056_bib9","first-page":"1","article-title":"Therapeutic effect of oridonin against inflammatory bowel disease involves inhibition of intestinal fibrosis via NF-\u03baB pathway","volume":"34","author":"Wang","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.jss.2023.12.056_bib10","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/ol4015865","article-title":"Overcoming synthetic challenges of oridonin A-ring structural diversification: regio- and stereoselective installation of azides and 1,2,3-triazoles at the C-1, C-2, or C-3 position","volume":"15","author":"Ding","year":"2013","journal-title":"Org Lett"},{"key":"10.1016\/j.jss.2023.12.056_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jss.2015.07.042","article-title":"Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis","volume":"199","author":"Bohanon","year":"2015","journal-title":"J Surg Res"},{"key":"10.1016\/j.jss.2023.12.056_bib12","doi-asserted-by":"crossref","first-page":"E1567","DOI":"10.3390\/ijms19061567","article-title":"Luteolin-mediated inhibition of hepatic stellate cell activation via suppression of the STAT3 pathway","volume":"19","author":"Cummins","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jss.2023.12.056_bib13","doi-asserted-by":"crossref","first-page":"100652","DOI":"10.1039\/C6RA17459K","article-title":"STAT3 inhibition suppresses hepatic stellate cell fibrogenesis: HJC0123, a potential therapeutic agent for liver fibrosis","volume":"6","author":"Nunez Lopez","year":"2016","journal-title":"RSC Adv"},{"key":"10.1016\/j.jss.2023.12.056_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049194","article-title":"Luteolin induces carcinoma cell apoptosis through binding Hsp90 to suppress constitutive activation of STAT3","volume":"7","author":"Fu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jss.2023.12.056_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pharep.2015.08.015","article-title":"The heat shock protein 90 inhibitor, 17-AAG, attenuates thioacetamide induced liver fibrosis in mice","volume":"68","author":"Abu-Elsaad","year":"2016","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.jss.2023.12.056_bib17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1124\/jpet.109.151860","article-title":"Heat shock protein 90 inhibitor induces apoptosis and attenuates activation of hepatic stellate cells","volume":"330","author":"Myung","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jss.2023.12.056_bib18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2174\/156652409788488757","article-title":"17 AAG for HSP90 inhibition in cancer--from bench to bedside","volume":"9","author":"Usmani","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jss.2023.12.056_bib19","doi-asserted-by":"crossref","first-page":"CNS87","DOI":"10.2217\/cns-2022-0005","article-title":"A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma","volume":"11","author":"de Groot","year":"2022","journal-title":"CNS Oncol"},{"key":"10.1016\/j.jss.2023.12.056_bib22","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.2174\/0929867321666140414100831","article-title":"IL-6 activated JAK\/STAT3 pathway and sensitivity to Hsp90 inhibitors in multiple myeloma","volume":"21","author":"Kolosenko","year":"2014","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jss.2023.12.056_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1478-811X-7-17","article-title":"HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells","volume":"7","author":"Schoof","year":"2009","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jss.2023.12.056_bib24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00204-015-1543-4","article-title":"Experimental models of liver fibrosis","volume":"90","author":"Crespo Yanguas","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.jss.2023.12.056_bib25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.jss.2023.12.056_bib26","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3390\/cells11111783","article-title":"Genetic characterization of rat hepatic stellate cell line HSC-T6 for in\u00a0vitro cell line authentication","volume":"11","author":"Nanda","year":"2022","journal-title":"Cells"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480424000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480424000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T21:59:44Z","timestamp":1717192784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480424000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":21,"alternative-id":["S0022480424000623"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2023.12.056","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Oridonin Analog CYD0682 Inhibits Hepatic Stellate Cell Activation via the Heat Shock Protein 90\u2013Dependent STAT3 Pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2023.12.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}